目的: 本研究预对比同位素32 P 胶体注射与博来霉素注射治疗海绵状血管瘤的疗效。方法: 分析
2014～ 2016 期间在内蒙古医科大学附属医院治疗的海绵状血管瘤病人56 例( 其中32P 胶体注射治疗35 例，博来
霉素注射治疗21 例) ，瘤体直径5．0～ 16．5mm，观察疗效及其副作用。结果: 32P 胶体注射与博来霉素注射治疗海
绵状血管瘤后瘤体明显缩小，随访无继续发展。32P 胶体注射治疗海绵状血管瘤的治愈率为89．3%，博来霉素注
射治疗海绵状血管瘤的治愈率为92．4%，差异有统计学意义( P＜0．05) ; 两种治疗方法病人均未见血细胞减少，32P
胶体注射治疗后部分病人遗留色素异常或瘢痕生长，博来霉素注射未见遗留色素异常或瘢痕生长。结论: 博来
霉素注射治疗海绵状血管瘤疗效明确，副作用小，是治疗海绵状血管瘤较理想的方法。

Objective: This study compares the efficacy of isotope 32P colloid and bleomycin in
treating of cavernous hemangioma．Methods: 56 cases of cavernous hemangioma treated by our department
were analyzed from 2014 to 2016．Among them， 35 cases were treated with32P colloid and 21 cases
were treated with bleomycin．The tumor diameter was 1．2～6．8for treating cavernous hemangioma，while
and the cure rate of bleomycin was 92．4%．No reduction of cytopenia was observed in either of the two
methods．Some patients with hypochromic or scarring remained after32P colloid injection．No blemishes or
cm，and the curative effect was observed．Ｒesults: Cavernous hemangioma significantly reduced by32 P
colloid or bleomycin injection，hemangioma did not continue to develop in the follow－up．The cure rate
of isotope32P colloid was 89．3%scarring were observed with bleomycin injection．Conclusion: Bleomycin
is an ideal method for the treatment of cavernous hemangioma．

Ｒ817．5

 收稿日期: 2017－12－05; 修回日期: 2018－02－27
基金项目: 内蒙古自然科学基金面上项目( 2016MS0825)
作者简介: 常培叶( 1975－) ，女，内蒙古医科大学核医学科副主任医师。